Literature DB >> 28522108

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

Emma L Barber1, Kemi M Doll2, Paola A Gehrig3.   

Abstract

OBJECTIVES: Readmission after surgery is a quality metric hypothesized to reflect the quality of care in the index hospitalization. We examined the link between readmissions and a surrogate of surgical quality - major postoperative complication - among ovarian cancer patients.
METHODS: Patients who underwent surgery for ovarian cancer between 2012 and 2013 were identified from the National Surgical Quality Improvement Project (NSQIP). Major complications were defined as grade 3 or ≥complications on the validated Claviden-Dindo scale and included both NSQIP and non-NSQIP defined complications based on readmission ICD-9 code. Readmissions and complications within 30-days of surgery were analyzed using rate ratios and modified Poisson regression.
RESULTS: We identified 2806 ovarian cancer patients of whom 9.1% (n=259) experienced an unplanned readmission. Overall major complication rate was 10.9% (n=307). Major complications in the index hospitalization were not associated with subsequent readmission (RR 1.2, 95% CI 0.7-1.9). Overall, 41.4% of readmissions were not attributable to any major postoperative complication. Of the unplanned readmissions, 55.2% (n=143) never experienced a NSQIP-defined major complication. Of these 143 patients, the reason for readmission was known for 107 patients and was: 28.0% non-NSQIP-defined major complications; 16.8% cancer or other medical factors; 22.4% minor complications; and 32.7% symptoms without a diagnosis of complication.
CONCLUSIONS: Forty percent of unplanned readmissions after ovarian cancer surgery occur among patients who have not experienced a major postoperative complication. Quality metric benchmarks and efforts to decrease readmissions should account for this high percentage of readmissions not associated with a major complication.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ovarian cancer; Postoperative complication; Postoperative readmission; Surgical quality

Mesh:

Year:  2017        PMID: 28522108      PMCID: PMC5614497          DOI: 10.1016/j.ygyno.2017.05.012

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Underlying reasons associated with hospital readmission following surgery in the United States.

Authors:  Ryan P Merkow; Mila H Ju; Jeanette W Chung; Bruce L Hall; Mark E Cohen; Mark V Williams; Thomas C Tsai; Clifford Y Ko; Karl Y Bilimoria
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

2.  Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Mira Shiloach; Stanley K Frencher; Janet E Steeger; Katherine S Rowell; Kristine Bartzokis; Majed G Tomeh; Karen E Richards; Clifford Y Ko; Bruce L Hall
Journal:  J Am Coll Surg       Date:  2009-11-22       Impact factor: 6.113

3.  Readmissions after major gynecologic oncology surgery.

Authors:  Shitanshu Uppal; Courtney Penn; Marcela G Del Carmen; J Alejandro Rauh-Hain; R Kevin Reynolds; Laurel W Rice
Journal:  Gynecol Oncol       Date:  2016-03-12       Impact factor: 5.482

4.  A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery.

Authors:  Emma L Barber; Sarah Rutstein; William C Miller; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2015-10-23       Impact factor: 5.482

5.  Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma.

Authors:  Janelle M Fauci; Kellie E Schneider; Peter J Frederick; Gregory Wilding; Joe Consiglio; Amelia L Sutton; Larry C Kilgore; Mack N Barnes
Journal:  Int J Gynecol Cancer       Date:  2011-07       Impact factor: 3.437

6.  Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma.

Authors:  Rachel M Clark; Whitfield B Growdon; Andrew Wiechert; David Boruta; Marcela Del Carmen; Anne Kathryn Goodman; Leslie Bradford; Alejandro Rauh-Hain; John O Schorge
Journal:  Gynecol Oncol       Date:  2013-06-05       Impact factor: 5.482

7.  A scoring system to predict unplanned intubation in patients having undergone major surgical procedures.

Authors:  May Hua; Joanne E Brady; Guohua Li
Journal:  Anesth Analg       Date:  2012-04-27       Impact factor: 5.108

8.  A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications.

Authors:  Elise H Lawson; Rachel Louie; David S Zingmond; Robert H Brook; Bruce L Hall; Lein Han; Michael Rapp; Clifford Y Ko
Journal:  Ann Surg       Date:  2012-12       Impact factor: 12.969

9.  Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.

Authors:  Anna Fagotti; Gabriella Ferrandina; Giuseppe Vizzielli; Francesco Fanfani; Valerio Gallotta; Vito Chiantera; Barbara Costantini; Pasquale Alessandro Margariti; Salvatore Gueli Alletti; Francesco Cosentino; Lucia Tortorella; Giovanni Scambia
Journal:  Eur J Cancer       Date:  2016-03-19       Impact factor: 9.162

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  1 in total

1.  Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?

Authors:  Emma L Barber; Emma C Rossi; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2017-09-21       Impact factor: 5.482

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.